Join Now

Memberzone

Phoenix PharmaLabs Inc

Categories

Pharmaceutical

About Us

Phoenix has developed a novel class of poly-receptor morphinans with strong potential to replace the currently available opioid pain medicines that are euphoric, addictive and pose risk of death.

Rep/Contact Info

Card image cap
Timmy Chou
Vice President, CFO